N

Nanoform Finland Oyj
OMXH:NANOFH

Watchlist Manager
Nanoform Finland Oyj
OMXH:NANOFH
Watchlist
Price: 1.11 EUR -0.89% Market Closed
Market Cap: 94.9m EUR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

NANOFH Price Targets Summary
Nanoform Finland Oyj

Wall Street analysts forecast NANOFH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NANOFH is 3.14 EUR with a low forecast of 3.03 EUR and a high forecast of 3.41 EUR.

NANOFH Lowest Forecast
Wall Street Target
3.03 EUR
173% Upside
NANOFH Average Forecast
Wall Street Target
3.14 EUR
183% Upside
NANOFH Highest Forecast
Wall Street Target
3.41 EUR
207% Upside
Lowest
Price Target
3.03 EUR
173% Upside
Average
Price Target
3.14 EUR
183% Upside
Highest
Price Target
3.41 EUR
207% Upside
Nanoform Finland Oyj Competitors:
Price Targets
TECN
Tecan Group AG
25% Upside
A
AKUMS
Akums Drugs and Pharmaceuticals Ltd
32% Upside
SYNGENE
Syngene International Ltd
13% Upside
300759
Pharmaron Beijing Co Ltd
25% Upside
TECN
Tecan Group AG
25% Upside
A
AKUMS
Akums Drugs and Pharmaceuticals Ltd
32% Upside
SYNGENE
Syngene International Ltd
13% Upside
300759
Pharmaron Beijing Co Ltd
25% Upside
CTKB
Cytek Biosciences Inc
56% Upside
TARSONS
Tarsons Products Ltd
24% Upside
F
FLB
Fluidigm Corp
91% Upside
MTD
Mettler-Toledo International Inc
6% Upside

Revenue
Forecast

Revenue Estimate
Nanoform Finland Oyj

For the last 6 years the compound annual growth rate for Nanoform Finland Oyj's revenue is 51%. The projected CAGR for the next 3 years is 85%.

51%
Past Growth
85%
Estimated Growth
Estimates Accuracy
-23%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Nanoform Finland Oyj

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Nanoform Finland Oyj

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
What are analyst estimates?

See Also

Summary
NANOFH intrinsic value, competitors valuation, and company profile.
DCF Valuation
NANOFH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NANOFH stock valuation using valuation multiples.
Wall Street Estimates
NANOFH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NANOFH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NANOFH's stock price target?
Price Target
3.14 EUR

According to Wall Street analysts, the average 1-year price target for NANOFH is 3.14 EUR with a low forecast of 3.03 EUR and a high forecast of 3.41 EUR.

What is Nanoform Finland Oyj's Revenue forecast?
Projected CAGR
85%

For the last 6 years the compound annual growth rate for Nanoform Finland Oyj's revenue is 51%. The projected CAGR for the next 3 years is 85%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 265,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.